These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 15037858

  • 1. Olanzapine/Fluoxetine (Symbyax) for bipolar depression.
    Med Lett Drugs Ther; 2004 Mar 15; 46(1178):23-4. PubMed ID: 15037858
    [No Abstract] [Full Text] [Related]

  • 2. Olanzapine and olanzapine-fluoxetine combination treatment and bipolar I depression.
    Williams AB, Adetunji BA.
    Arch Gen Psychiatry; 2005 Sep 15; 62(9):1052; author reply 1052. PubMed ID: 16143737
    [No Abstract] [Full Text] [Related]

  • 3. Effects of olanzapine alone and olanzapine/fluoxetine combination on health-related quality of life in patients with bipolar depression: secondary analyses of a double-blind, placebo-controlled, randomized clinical trial.
    Shi L, Namjoshi MA, Swindle R, Yu X, Risser R, Baker RW, Tohen M.
    Clin Ther; 2004 Jan 15; 26(1):125-34. PubMed ID: 14996525
    [Abstract] [Full Text] [Related]

  • 4. A 24-week open-label extension study of olanzapine-fluoxetine combination and olanzapine monotherapy in the treatment of bipolar depression.
    Corya SA, Perlis RH, Keck PE, Lin DY, Case MG, Williamson DJ, Tohen MF.
    J Clin Psychiatry; 2006 May 15; 67(5):798-806. PubMed ID: 16841630
    [Abstract] [Full Text] [Related]

  • 5. Olanzapine/fluoxetine: a review of its use in the treatment of acute bipolar depression.
    Deeks ED, Keating GM.
    Drugs; 2008 May 15; 68(8):1115-37. PubMed ID: 18484802
    [Abstract] [Full Text] [Related]

  • 6. Analyses of treatment-emergent mania with olanzapine/fluoxetine combination in the treatment of bipolar depression.
    Keck PE, Corya SA, Altshuler LL, Ketter TA, McElroy SL, Case M, Briggs SD, Tohen M.
    J Clin Psychiatry; 2005 May 15; 66(5):611-6. PubMed ID: 15889948
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Acute and maintenance treatments for bipolar depression.
    Ketter TA.
    J Clin Psychiatry; 2014 Apr 15; 75(4):e10. PubMed ID: 24813411
    [Abstract] [Full Text] [Related]

  • 9. Olanzapine/fluoxetine: a review of its use in patients with treatment-resistant major depressive disorder.
    Croxtall JD, Scott LJ.
    CNS Drugs; 2010 Mar 15; 24(3):245-62. PubMed ID: 20155998
    [Abstract] [Full Text] [Related]

  • 10. A preliminary, randomized trial of fluoxetine, olanzapine, and the olanzapine-fluoxetine combination in women with borderline personality disorder.
    Zanarini MC, Frankenburg FR, Parachini EA.
    J Clin Psychiatry; 2004 Jul 15; 65(7):903-7. PubMed ID: 15291677
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Comparison of fluoxetine, olanzapine, and combined fluoxetine plus olanzapine initial therapy of bipolar type I and type II major depression--lack of manic induction.
    Amsterdam JD, Shults J.
    J Affect Disord; 2005 Jul 15; 87(1):121-30. PubMed ID: 15923042
    [Abstract] [Full Text] [Related]

  • 13. Comparative efficacy and acceptability of drug treatments for bipolar depression: a multiple-treatments meta-analysis.
    Taylor DM, Cornelius V, Smith L, Young AH.
    Acta Psychiatr Scand; 2014 Dec 15; 130(6):452-69. PubMed ID: 25283309
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Questions & answers. What is Symbyax, the new drug being marketed for the treatment of bipolar depression.
    Miller MC.
    Harv Ment Health Lett; 2004 Aug 15; 21(2):8. PubMed ID: 15325983
    [No Abstract] [Full Text] [Related]

  • 16. The combination of olanzapine and fluoxetine in mood disorders.
    Shelton RC.
    Expert Opin Pharmacother; 2003 Jul 15; 4(7):1175-83. PubMed ID: 12831342
    [Abstract] [Full Text] [Related]

  • 17. Economic impact of olanzapine plus fluoxetine combination therapy among patients treated for depression: a pilot study.
    Corey-Lisle PK, Birnbaum H, Greenberg P, Marynchenko M, Dube S.
    Psychopharmacol Bull; 2003 Jul 15; 37(3):90-8. PubMed ID: 14608242
    [Abstract] [Full Text] [Related]

  • 18. Genetic association study of treatment response with olanzapine/fluoxetine combination or lamotrigine in bipolar I depression.
    Perlis RH, Adams DH, Fijal B, Sutton VK, Farmen M, Breier A, Houston JP.
    J Clin Psychiatry; 2010 May 15; 71(5):599-605. PubMed ID: 20021991
    [Abstract] [Full Text] [Related]

  • 19. Olanzapine augmentation of fluoxetine in body dysmorphic disorder.
    Phillips KA.
    Am J Psychiatry; 2005 May 15; 162(5):1022-3. PubMed ID: 15863817
    [No Abstract] [Full Text] [Related]

  • 20. A review of FDA-approved treatment options in bipolar depression.
    McIntyre RS, Cha DS, Kim RD, Mansur RB.
    CNS Spectr; 2013 Dec 15; 18 Suppl 1():4-20; quiz 21. PubMed ID: 24237641
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.